Rohto Pharmaceutical Overview

  • Year Founded
  • 1899

Year Founded

  • Status
  • Public

  • Employees
  • 11,021

Employees

  • Stock Symbol
  • 4527

Stock Symbol

  • Investments
  • 52

  • Share Price
  • $16.48
  • (As of Friday Closing)

Rohto Pharmaceutical General Information

Description

Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.

Contact Information

Website
www.rohto.co.jp
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1-8-1, Tatsumi-nishi
  • Ikuno-ku
  • Osaka, 544-8666
  • Japan
+81
Primary Industry
Personal Products
Stock Exchange
TKS
Vertical(s)
Corporate Office
  • 1-8-1, Tatsumi-nishi
  • Ikuno-ku
  • Osaka, 544-8666
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rohto Pharmaceutical Stock Performance

As of 20-Nov-2026, Rohto Pharmaceutical’s stock price is $16.48. Its current market cap is $3.71B with 225M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$16.48 $16.70 $14.05 - $19.60 $3.71B 225M 1.26M $0.93

Rohto Pharmaceutical Financials Summary

As of 30-Sep-2026, Rohto Pharmaceutical has a trailing 12-month revenue of $2.28B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 3,973,774 3,372,369 3,298,333 4,026,707
Revenue 2,277,706 2,280,479 2,023,795 1,874,457
EBITDA 412,711 426,937 358,385 338,280
Net Income 210,269 227,215 202,239 214,105
Total Assets 3,182,783 3,038,766 2,920,557 2,287,248
Total Debt 311,398 376,859 383,641 69,336
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rohto Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rohto Pharmaceutical‘s full profile, request access.

Request a free trial

Rohto Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty car
Personal Products
Osaka, Japan
11,021 As of 2026

Tokyo, Japan
 

Tokyo, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rohto Pharmaceutical Competitors (21)

One of Rohto Pharmaceutical’s 21 competitors is Lion (Household Products), a Corporation company based in Tokyo, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lion (Household Products) Corporation Tokyo, Japan
Kao Corporation Tokyo, Japan
The Body Shop Cyprus Corporation Limassol, Cyprus
The Body Shops Private Equity-Backed Littlehampton, United Kingdom
CetaphilS Corporation Dusseldorf, Germany
You’re viewing 5 of 21 competitors. Get the full list »

Rohto Pharmaceutical Patents

Rohto Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7896832-B1 Composition containing crocetin Active 22-Jan-2026
JP-7945526-B1 Steroid-containing composition Active 05-Sep-2025
JP-7876079-B1 A composition containing dextran sulfate or its salt, royal jelly extract, and bilberry leaf extract. Active 27-Jun-2025
JP-7869540-B1 Oral composition for suppressing methane gas generation Active 05-Jun-2025
JP-2026180201-A Uv absorber-containing nanoparticles and topical compositions containing the same Pending 30-Apr-2025
To view Rohto Pharmaceutical’s complete patent history, request access »

Rohto Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rohto Pharmaceutical Investments & Acquisitions (52)

Rohto Pharmaceutical’s most recent deal was a Merger/Acquisition with OP Bio Factory. The deal was made on 04-Aug-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
OP Bio Factory 04-Aug-2026 Merger/Acquisition Consulting Services (B2B)
Magic Cod 08-Jul-2026 Merger/Acquisition Personal Products
Thann Oryza 29-May-2026 Merger/Acquisition Personal Products
ULUCUS PARK 18-Apr-2026 Early Stage VC Education and Training Services (B2B)
NeuralPort 08-Apr-2026 Seed Round Other Business Products and Services
You’re viewing 5 of 52 investments and acquisitions. Get the full list »

Rohto Pharmaceutical ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

28.13 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Household Products

Industry

of 104

Rank

Percentile

Personal Products

Subindustry

of 84

Rank

Percentile

To view Rohto Pharmaceutical’s complete esg history, request access »

Rohto Pharmaceutical Exits (5)

Rohto Pharmaceutical’s most recent exit was on 13-Mar-2025 from Hutzper. The exit was categorized as with 6 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Hutzper 13-Mar-2025 Completed
  • 6 buyers
Kuradashi 06-Jul-2022 Completed
  • 5 buyers
Agri Holdings 08-May-2018 Completed
  • 3 buyers
Flipkart Health+ 30-May-2017 Completed
Alina Vision Corporate Completed
  • 2 buyers
To view Rohto Pharmaceutical’s complete exits history, request access »

Rohto Pharmaceutical Affiliates

Subsidiaries (14)

Name Industry Location Year Founded
Rohto Sigmapharm Holding Vienna, Austria 2024
Naris Cosmetics Vietnam Hanoi, Vietnam 2014
Magic Cod Veternik, Serbia 2011
OP Bio Factory Uruma, Japan 2006
Thann Oryza Bangkok, Thailand 2003
You’re viewing 5 of 14 affiliates. Get the full list.  »

Rohto Pharmaceutical FAQs

  • When was Rohto Pharmaceutical founded?

    Rohto Pharmaceutical was founded in 1899.

  • Where is Rohto Pharmaceutical headquartered?

    Rohto Pharmaceutical is headquartered in Osaka, Japan.

  • What is the size of Rohto Pharmaceutical?

    Rohto Pharmaceutical has 11,021 total employees.

  • What industry is Rohto Pharmaceutical in?

    Rohto Pharmaceutical’s primary industry is Personal Products.

  • Is Rohto Pharmaceutical a private or public company?

    Rohto Pharmaceutical is a Public company.

  • What is Rohto Pharmaceutical’s stock symbol?

    The ticker symbol for Rohto Pharmaceutical is 4527.

  • What is the current stock price of Rohto Pharmaceutical?

    As of 20-Nov-2026 the stock price of Rohto Pharmaceutical is $16.48.

  • What is the current market cap of Rohto Pharmaceutical?

    The current market capitalization of Rohto Pharmaceutical is $3.71B.

  • What is Rohto Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Rohto Pharmaceutical is $2.28B.

  • Who are Rohto Pharmaceutical’s competitors?

    Lion (Household Products), Kao, The Body Shop Cyprus, The Body Shops, and CetaphilS are some of the 21 competitors of Rohto Pharmaceutical.

  • What is Rohto Pharmaceutical’s annual earnings per share (EPS)?

    Rohto Pharmaceutical’s EPS for 12 months was $0.93.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process